Chester County News and Community Website
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their drug ENHERTU® (fam-trastuzumab deruxtecan-nxki) achieved highly statistically significant and clinically meaningful improvements in invasive disease-free survival (IDFS) compared to trastuzumab …
ENHERTU Shows Strong Results in Early Breast Cancer Trial Read More WILMINGTON, DE — AstraZeneca announced the launch of AstraZeneca Direct, an online platform aimed at expanding access to its medicines by offering eligible patients transparent cash prices and home delivery. …
AstraZeneca Launches Direct-to-Patient Platform With Home Delivery Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for …
FDA Grants Priority Review for ENHERTU Combo in Advanced Breast Cancer Read More WILMINGTON, DE — The U.S. prescribing information for AIRSUPRA now includes results from the Phase IIIb BATURA trial, which demonstrated that the medication significantly reduced severe asthma exacerbations in patients …
AIRSUPRA Label Expanded With Evidence of Risk Reduction in Mild Asthma Read More WILMINGTON, DE — AstraZeneca announced positive interim results from its Phase III TULIP-SC trial showing that subcutaneous administration of SAPHNELO (anifrolumab) significantly reduced disease activity in patients with systemic lupus …
AstraZeneca Reports Positive Phase III Data for Subcutaneous Lupus Therapy Read More
WILMINGTON, DE — New data from the BaxHTN Phase III trial indicate that baxdrostat, an investigational aldosterone synthase inhibitor, achieved significant reductions in systolic blood pressure among patients with uncontrolled …
Phase III Trial Shows Baxdrostat Significantly Lowers Blood Pressure in Hard-to-Treat Hypertension Read More WILMINGTON, DE — AstraZeneca has introduced FluMist Home, a first-of-its-kind at-home delivery and self-administration service for its nasal spray flu vaccine, FLUMIST® (Influenza Vaccine Live, Intranasal). The new option allows …
AstraZeneca Launches First At-Home Influenza Vaccine Service With FluMist Home Read More WILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) in the treatment of …
AstraZeneca’s IMFINZI® Granted Priority Review for Early-Stage Gastric Cancer Treatment Read More WILMINGTON, DE — AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals …
AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site Read More